GI & Endoscopy

Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of Sept. 12 to Sept. 16, 2016.

McMaster University in Ontario, Canada, will study the efficacy of fecal transplants on children suffering from inflammatory bowel disease. Nikhil Pai, MD — an assistant professor in the university's department of pediatrics, division of gastroenterology and nutrition — is the…

Here are five gastroenterologists in the news this past week.

Researchers at the University of British Columbia in Vancouver, Canada, are developing a drug treatment to reverse fibrosis in Crohn’s disease patients. Their research, which details how a hormone receptor mutation prevented fibrotic disease during tests on mice, was recently…

Providing a support network for patients suffering from inflammatory bowel disease proves helpful for patient recovery, according to a Pain Medicine News report.

The Nashville-based pharmaceutical company Cumberland Pharmaceuticals has received FDA clearance for a randomized, placebo-controlled Phase II clinical study. The study will investigate Portaban, a treatment Cumberland Pharmaceuticals developed for liver cyrossis patients.

University Gastroenterology and its 19 offices were victims of a data hacking scam, where an individual gained access to the network, copied information for 14,000 patients and then encrypted it, NBC reports. 

The Kentucky-based University of Louisville has received a five-year $11.5 million grant from the NIH's Centers of Biomedical Research Excellence, according to the Louisville Courier-Journal.

Nicole Bradberry will be the next CEO of Captify Health. Here's what you need to know.

Here are six updates on key gastroenterology and endoscopy companies.